Clinical Trial Update: INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/2 study evaluating the combination of INO-5401 and INO-9012 with atezolizumab in locally advanced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• INO-5401 (INO-5401)
• INO-9012 (INO-9012)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Inovio Pharmaceuticals | Conditions: Urothelial Carcinoma | Phase 1, Phase 2 | Status: COMPLETED